Full-length CD44 exerts a tumor-suppressive function and is overexpressed in benign prostate epithelium, while CD44 splice variants (CD44v7-10) exhibit pro-invasive activity and are overexpressed in PCa. This evidence concerns the gene CD44 and neoplasm.